With an exclusive focus on empowering translational neurodegenerative research, the 6th Annual World CNS Summit remains the only industry-specific conference to help bridge the gap for translational development.
Bringing together over 100 senior scientists and executives from across biopharma and academia, join us to challenge traditional thinking in the development of efficacious treatments against neurodegeneration.
This is a unique opportunity to engage with the leading minds in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies.
What’s new for this year?
“Every speaker was excellent. A very informative and thought provoking series of presentations.”
National Institute Neurologic Disease and Stroke
"A great meeting. The networking opportunities were fantastic."
"I liked the breadth of commercial development (pre-clinical up through clinical) included in the program. The meeting is a must go for anyone seriously considering drug development."
St. Lawrence University